16 documents found, page 1 of 2

Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis An...

Background: On the basis of recent clinical trial data for the treatment of drug-susceptible and drug-resistant tuberculosis (TB), the American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America have updated clinical practice guidelines for TB treatment in children and adults in settings in which mycobacterial cultures, mol...

Viewpoint on WHO implementation guidance on tuberculosis infection prevention a...

Clinical Standards for Diagnosis, Treatment and Prevention of Post-COVID-19 Lun...

BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice' care for the diagnosis, treatment and prevention of post-COVID-19 lung disease.METHODS: A panel of international experts representing scientific societies, associations and groups active in post-COVID-19 lung disease was identified; 45 completed a Delphi process. A 5-point Likert scale indicated level of agreement with the...

Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort

Background Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and COVID-19. Methods We collected data from 174 centres in 31 countries on all patients affected by COVID-19 and TB between 1 March 2020 and 30 September 2022. Patients were followed-up until cure, death or end...

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculos...

Objectives: Although evidence is growing on the overall impact of the COVID-19 pandemic on tuberculosis (TB) services, global studies based on national data are needed to better quantify the extent of the impact and the countries' preparedness to tackle the two diseases. The aim of this study was to compare the number of people with new diagnoses or recurrence of TB disease, the number of drug-resistant (DR)-TB...

COVID-19 Related Hospital Re-organization and Trends in Tuberculosis Diagnosis ...

[No abstract available]

Impact of the COVID-19 pandemic on tuberculosis services

Background: In Portugal, Outpatient Tuberculosis Centres (OTBC) are responsible for the diagnosis, treatment, screening and prevention of tuberculosis (TB), and only severe or resistant cases are hospitalized. Aim: To understand how infection control norms and standards were applied and how these centres responded during the pandemic. Method: We sent an electronic questionnaire to all coordinators of OTBC. The ...

COVID-19 media communications: a new role for health professionals?

[No abstract available]

New and repurposed drugs to treat multidrug- and extensively drug-resistant tub...

Multidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respectively) continue to represent a challenge for clinicians and public health authorities. Unfortunately, although there have been encouraging reports of higher success rates, the overall rate of favorable outcomes of M/XDR-TB treatment is only 54%, or much lower when the spectrum of drug resistance is beyond that of XDR-TB. ...

Strengthening tuberculosis control to advance towards elimination: The 2018 Rev...

n/a